Javier Sánchez Ramírez

Years Active: 2019-2023
Publications (10 Years): 4

This page only lists publications with an associated author ORCID identifier.

Publications

Nicola Gaynor, Alfonso Blanco, Stephen F Madden, Barry Moran, Jean M Fletcher, Damien Kaukonen, Javier Sánchez Ramírez, Alex J Eustace, Martina S J McDermott, Alexandra Canonici, Sinead Toomey, Ausra Teiserskiene, Bryan T Hennessy, Norma O'Donovan, John Crown, Denis M Collins
Alterations in immune cell phenotype and cytotoxic capacity in HER2+ breast cancer patients receiving HER2-targeted neo-adjuvant therapy. British journal of cancer (2023)
Javier Sánchez Ramírez, Yanelys Morera Díaz, Mónica Bequet-Romero, Marta Ayala Ávila
Potential mechanisms involved on how systemic IgG antibodies specific to vascular endothelial growth factor (VEGF) and induced by active immunotherapy decrease platelet derived free-VEGF. Platelets 33 (7) (2022)
Javier Sánchez Ramírez, Yanelys Morera Díaz, Mónica Bequet-Romero, Francisco Hernández-Bernal, Yenima Martín Bauta, Katty-Hind Selman-Housein Bernal, Ana Victoria de la Torre Santos, Mariela Pérez de la Iglesia, Lian Trimiño Lorenzo, null null, Marta Ayala Avila
Specific humoral response in cancer patients treated with a VEGF-specific active immunotherapy procedure within a compassionate use program. BMC immunology 21 (1) (2020)
Javier Sánchez Ramírez, Mónica Bequet-Romero, Yanelys Morera Díaz, Francisco Hernández-Bernal, Marta Ayala Avila
Does VEGF-targeted active immunotherapy induce complete abrogation of platelet VEGF levels? BMC research notes 12 (1) (2019)

Javier Sánchez Ramírez.css-eqlu8i{font-size:small;padding-left:4px;}